International Journal of Clinical Transfusion Medicine最新文献

筛选
英文 中文
A Study of Blood Transfusion in Pediatric Patients at a Teaching Hospital, Aden, Yemen 也门亚丁某教学医院儿科患者输血的研究
International Journal of Clinical Transfusion Medicine Pub Date : 2021-02-01 DOI: 10.2147/IJCTM.S293720
Abdul-Wahab M Al-Saqladi, Tarneem A Albanna
{"title":"A Study of Blood Transfusion in Pediatric Patients at a Teaching Hospital, Aden, Yemen","authors":"Abdul-Wahab M Al-Saqladi, Tarneem A Albanna","doi":"10.2147/IJCTM.S293720","DOIUrl":"https://doi.org/10.2147/IJCTM.S293720","url":null,"abstract":"Background: Blood transfusion is an essential supportive therapy, used over a wide variety of clinical circumstances. Patterns of blood transfusion in pediatric patients are less char-acterized, and in Yemen information is chronically lacking. This study was aimed to assess the use of blood transfusion in children at a single center in a low resource setting. Materials and Methods: A descriptive, cross-sectional study was conducted on all children (≤16 years) who received blood transfusion in the Pediatric Department, Al-Sadaqa Teaching Hospital, Aden, Yemen over a time period of seven months. Data on age, gender, indications, type of blood product transfused, and adverse reactions were collected. Results: There were 360 transfusion episodes given to 202 patients, at a ratio of 2.3 transfusions per patient. The average age of transfused children was 5.63±4.63 years and 63.4% were male. Children ≤5 years comprised 50% of recipients. Single transfusion was most common (56.7%). Major indications were hemoglobinopathies (43.6%), and oncologic diseases (25.3%). The overall mean of pretransfusion hemoglobin (Hb) was 6.7±2.3 g/dL, varying by primary diagnosis, and the average Hb increment was 1.4 g/dL. The main types of transfused blood were red blood cell concentrates (58.9%) and whole blood (26.4%). Blood group O Rhesus D positive was the most requested (57.5%), followed by A positive (21.9%). Adverse transfusion reactions occurred in 4.4%, including febrile nonhemolytic (56.2%), allergic (37.5%) and transfusion-associated dyspnea (6.3%). Conclusion: Blood transfusion is a frequent supportive therapy in pediatric patients with various medical illnesses in this population. Most common indications were hemoglobinopathies and oncologic diseases. Regular review of blood transfusion is fundamental to ensure better and more rational use of this precious resource.","PeriodicalId":383221,"journal":{"name":"International Journal of Clinical Transfusion Medicine","volume":"33 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122500761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Convalescent Plasma Therapy: An Effective Therapeutic Option to Treat COVID-19? A Narrative Review 恢复期血浆治疗:治疗COVID-19的有效选择?叙述性回顾
International Journal of Clinical Transfusion Medicine Pub Date : 2020-10-01 DOI: 10.2147/ijctm.s269691
I. Ray, Diana Sánchez, C. A. Robert, M. Robert
{"title":"Convalescent Plasma Therapy: An Effective Therapeutic Option to Treat COVID-19? A Narrative Review","authors":"I. Ray, Diana Sánchez, C. A. Robert, M. Robert","doi":"10.2147/ijctm.s269691","DOIUrl":"https://doi.org/10.2147/ijctm.s269691","url":null,"abstract":"December 2019 marked the emergence of a new deadly strain of the coronavirus family which unleashed an unprecedented pandemic named the coronavirus disease 2019 outbreak (COVID-19) upending lives all over the world We still do not have drugs or vaccines that specifically target this vile virus Hence, the need to find alternative therapeutic options is to optimize recovery and reduce the viral load due to COVID-19 Convalescent plasma (CP) therapy is a potential therapeutic option being explored all over the world In this study, we reviewed all relevant publications that mentioned the use of plasma therapy Out of the 61 articles, eight publications specifically explored CP therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients and were studied in detail during this review The plasma collected from convalescent COVID-19 patients contains neutralising antibodies which show potential benefit in reducing viral load and accelerating viral clearance with negative reverse transcriptase polymerase chain reaction (RT-PCR) test reports The concentration of neutralising antibodies also increased post CP therapy Improvement in clinical symptoms like fever, cough and dyspnoea was also reported Radiological findings before and after CP therapy showed reduced ground glass opacities and resorption of pneumonia in several SARS-CoV-2 patients Laboratory parameters also showed improvement as lymphocyte counts increased, and markers of inflammation like C-reactive protein (CRP), alanine aminotransferase (ALT) and aspartate aminotransferase (AST) reduced after plasma therapy There were no adverse reactions reported in any of the studies reviewed However, potential adverse reactions cannot be ruled out like circulatory overload and anaphylaxis Lack of large-scale clinical trials on CP therapy is a major shortcoming before this therapeutic modality starts being extensively used","PeriodicalId":383221,"journal":{"name":"International Journal of Clinical Transfusion Medicine","volume":"2672 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121251543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Anemia in Pediatric Critical Care 小儿危重症中的贫血
International Journal of Clinical Transfusion Medicine Pub Date : 2020-10-01 DOI: 10.2147/ijctm.s229764
Camille Jutras, J. Charlier, T. François, G. Du Pont-Thibodeau
{"title":"Anemia in Pediatric Critical Care","authors":"Camille Jutras, J. Charlier, T. François, G. Du Pont-Thibodeau","doi":"10.2147/ijctm.s229764","DOIUrl":"https://doi.org/10.2147/ijctm.s229764","url":null,"abstract":": Anemia is a common complication of pediatric critical illness; close to 75% of children that are admitted to the pediatric intensive care unit (PICU) are anemic at some point during their stay. The causes of anemia of critical illness are multifactorial and are most often attributable to inflammation and/or blood losses (iatrogenic or disease-related). The impact of anemia in critically ill children is unclear but given that hemoglobin is an important factor in the body’s oxygen-carrying capacity, low hemoglobin can result in insufficient oxygen delivery to vital organs and tissues especially in the context of an acute illness. The management of anemia of critical illness is yet to be developed. Transfusions of red blood cells are the fastest way to increase hemoglobin; however, they are associated with adverse events. Current recommendations suggest limiting transfusions to hemoglobin levels below 7g/dL in hemodynamically stabilized children. Iron and erythropoietin have been investigated to manage and/or prevent anemia; yet studies on these two therapeutic options have been either negative or inconclusive. Another approach to reduce or prevent anemia is to reduce blood testing and iatrogenic blood losses. Multiples strategies have shown promising results, such as small-volume phlebotomy, in-line blood testing and modifying physician behavior with regard to blood testing orders. Further studies are required to determine how efficient these interventions are to reduce the prevalence of anemia at PICU discharge. Anemia is a significant complication of critical illness and 50% of children are discharged from the PICU anemic. The long-term impact of this complication on these children is unknown, in particular the impact on their long-term neurocognitive development. Structured follow-up is required to understand the trajectory and consequences of anemia in this particular population.","PeriodicalId":383221,"journal":{"name":"International Journal of Clinical Transfusion Medicine","volume":"30 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132048386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Impact of Incorporation of Fibrinogen Concentrate in Blood Transfusion Management During Liver Transplantation: An Early Local (Single Centre) Experience 浓缩纤维蛋白原掺入对肝移植输血管理的影响:早期局部(单中心)经验
International Journal of Clinical Transfusion Medicine Pub Date : 2020-02-01 DOI: 10.2147/ijctm.s238816
Y. C. Ho, K. Lim, F. Lai
{"title":"Impact of Incorporation of Fibrinogen Concentrate in Blood Transfusion Management During Liver Transplantation: An Early Local (Single Centre) Experience","authors":"Y. C. Ho, K. Lim, F. Lai","doi":"10.2147/ijctm.s238816","DOIUrl":"https://doi.org/10.2147/ijctm.s238816","url":null,"abstract":"Background: Orthotopic liver transplantation surgery is associated with major bleeding, often requiring transfusions of blood products such as red cell concentrates, plasma, platelets and cryoprecipitate. Fibrinogen concentrate was made available in our institution in January 2017 and is increasingly being used as an alternative strategy to reduce transfusion requirements. Limited literature exists to show the effectiveness of fi brinogen concentrate on blood loss during liver transplantation surgery, as well as its impact on blood transfusion requirements. Methods: This is a retrospective, observational study conducted at a single, large, tertiary centre in Singapore to evaluate the impact of incorporating fi brinogen concentrate on blood transfusion requirements during orthotopic liver transplantation surgery from January 2014 to December 2018. Results: A total of 54 patients who underwent liver transplantation during this period were studied. Forty patients did not receive fi brinogen concentrate during the surgery while 14 patients did. No statistically signi fi cant difference was detected in the baseline preoperative characteristics of both groups of patients in terms of MELD or preoperative INR. The mean INR in patients who did not receive fi brinogen concentrate was 1.77 while that in patients who received fi brinogen concentrate was 2.21. While not statistically signi fi cant, clinically this may be of signi fi cance. There was a signi fi cant difference in the starting haemoglobin level of the patients, with a lower starting haemoglobin level in patients who received fi brinogen concentrate (p=0.039). No signi fi cant difference was noted in the amount of blood loss, amount of red cell transfusions and amount of fresh plasma transfused. Of note, patients who received fi brinogen concentrate had a signi fi cantly less amount of cryoprecipitate transfused compared to those who did not (p=0.002). Conclusion: The intraoperative use of fi brinogen concentrate did not seem to have any statistically signi fi cant difference in the amount of blood loss during surgery. However, the amount of cryoprecipitate used was signi fi cantly reduced with the introduction of fi brinogen concentrate.","PeriodicalId":383221,"journal":{"name":"International Journal of Clinical Transfusion Medicine","volume":"160 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133216498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Transfusion Safety: Lessons Learned In Ibero-America And Considerations For Their Global Applicability 输血安全:伊比利亚美洲的经验教训及其全球适用性的考虑
International Journal of Clinical Transfusion Medicine Pub Date : 2019-10-16 DOI: 10.2147/ijctm.s222634
J. R. Cruz
{"title":"Transfusion Safety: Lessons Learned In Ibero-America And Considerations For Their Global Applicability","authors":"J. R. Cruz","doi":"10.2147/ijctm.s222634","DOIUrl":"https://doi.org/10.2147/ijctm.s222634","url":null,"abstract":"The safety of blood used for transfusions has historically been the main focus of the international health community. In the Americas, during the first decade of the 21st Century, the attention switched to the patients who need transfusions and to the individuals who donate blood, that is, to transfusion safety. Timely and universal access to blood components implied adequate availability to sufficient blood components by patients who require transfusions in every hospital of every country. Clinical conditions and local non-medical factors influence decisions to admit and transfuse ill individuals. Locally-developed pertinent transfusion guidelines contribute to better estimate blood needs. Replacement blood donation hinders access to blood stocked in the hospitals blood banks and results in excessive component expiry and financial losses. Focusing on patient transfusion needs and on patient outcomes permits implementing national blood collection, processing and distribution, in consonance with the national health system. Analyses of general health conditions, by using the national Human Health Indexes, and the operational characteristics of blood services, by using the blood center density index, permit  identification of locally pertinent interventions to improve transfusion safety. For this article, the analytical approaches used in Ibero-America were applied to blood data from South-East Asian and African countries. Data collection and validation were identified as  priorities for Asian countries. Estimating blood component requirements at the local level and adjusting blood collection, processing and distribution systems are important in Africa. Key Words : blood safety, transfusion safety, blood donors, Human Health Index, Ibero-America French Title: Securite transfusionnelle: Lecons Apprises en Amerique Latine et Considerations Relatives a Leur Applicabilite Mondiale La securite du sang utilise pour les transfusions a toujours ete la principale preoccupation de la communaute internationale de la sante. Dans les Ameriques, au cours de la premiere decennie du 21e siecle, l'attention s'est portee sur les patients qui ont besoin de transfusions et sur les donneurs de sang, c'est-a-dire sur la securite transfusionnelle. L'acces universel et opportun aux composants sanguins impliquait une disponibilite suffisante en suffisamment de composants sanguins pour les patients necessitant une transfusion dans chaque hopital de chaque pays. Les conditions cliniques et les facteurs non medicaux locaux influencent les decisions d'admettre et de transfuser des personnes malades. Les  directives pertinentes en matiere de transfusion developpees localement contribuent a une meilleure estimation des besoins en sang. Le don de sang de remplacement empeche l'acces au sang stocke dans les banques de sang des hopitaux et entraine une peremption excessive des composants et des pertes financieres. Se concentrer sur les besoins des patients en matiere de transfusion ","PeriodicalId":383221,"journal":{"name":"International Journal of Clinical Transfusion Medicine","volume":"130 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133258330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potential of next-generation sequencing to match blood group antigens for transfusion 新一代测序技术用于血型抗原匹配的潜力
International Journal of Clinical Transfusion Medicine Pub Date : 2019-09-01 DOI: 10.2147/ijctm.s175142
A. Orzińska, K. Guz, E. Brojer
{"title":"Potential of next-generation sequencing to match blood group antigens for transfusion","authors":"A. Orzińska, K. Guz, E. Brojer","doi":"10.2147/ijctm.s175142","DOIUrl":"https://doi.org/10.2147/ijctm.s175142","url":null,"abstract":"Institute of Hematology and Transfusion Medicine, Department of Hematological and Transfusion Immunology, Warsaw, Poland Abstract: A review of the advances in applying next-generation sequencing (NGS) to transfusion medicine for the purpose of genotyping alleles encoding clinically important red blood cell and platelet antigens. NGS data from published studies confirm the possibility of antigen prediction based on sequencing of the whole genome, exome or targeted regions. What remains a challenge, to provide highly accurate NGS genotyping, is the further improvement of bioinformatic solutions for automated interpretation based on publicly accessible and improved reference databases appropriate for NGS methods as well as validation of a method based on the examination of a large number of individuals. There is no doubt, however, as to the future of NGS as a supplementary test used to provide highly compatible blood as well as to reduce the risk of patient’s alloimmunization. This is part of personalized medicine.","PeriodicalId":383221,"journal":{"name":"International Journal of Clinical Transfusion Medicine","volume":"2013 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133722849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Minimizing the need for transfusion in pediatric congenital heart surgery 减少小儿先心病手术中输血的需要
International Journal of Clinical Transfusion Medicine Pub Date : 2019-05-31 DOI: 10.2147/IJCTM.S168256
L. Caneo, G. Matte, T. Frey
{"title":"Minimizing the need for transfusion in pediatric congenital heart surgery","authors":"L. Caneo, G. Matte, T. Frey","doi":"10.2147/IJCTM.S168256","DOIUrl":"https://doi.org/10.2147/IJCTM.S168256","url":null,"abstract":"Luiz Fernando Caneo 1 Gregory S Matte Talya Frey 1Pediatric Cardiac Surgeon Heart Institute, University of Sao Paulo Medical School – Division of Pediatric Cardiac Surgery, Sao Paulo, Brazil; 2Department of Cardiac Surgery, Boston Children’s Hospital, Boston, MA, USA; 3Ward Family Heart Center, Children’s Mercy Hospital, Kansas City, MO, USA Abstract: Blood conservation has become an essential institutional initiative in cardiac surgery patients secondary to published reports associating transfusion with increased morbidity and mortality. Cardiopulmonary bypass (CPB) for children with congenital heart disease presents unique challenges in regard to transfusion practice. The circuit size relative to the pediatric patient’s circulating blood volume results in more hemodilution forcing clinicians to adopt several strategies to counteract this. It is generally agreed that the effects of hemodilution in this population are less well understood. That being said, there is evidence that neurologic outcomes are impacted by significant anemia in neonates and infants undergoing CPB. This adds to the level of concern clinicians should have when managing congenital heart surgery patients. Optimized surgical outcomes are dependent on neurologic outcomes. Specific transfusion guidelines for pediatric cardiac surgery still vary widely across institutions, and a safe minimum hematocrit on bypass has not been established. Evidence-based guidelines are more prevalent in adult cardiac surgery patients, but there are a growing number of reports for pediatrics. Clearly, well-defined operative strategies and a team approach will decrease blood product transfusions and minimize the associated risks in pediatric patients, especially in regard to neurologic outcomes. The ongoing development of evidence-based guidelines for pediatric perfusion will serve clinicians, and most importantly, their patients, well. The purpose of this review is to present current practice to limit blood transfusions in pediatric cardiac surgery exclusively inside the operating room and related to CPB as well as minimizing the side effects of the coagulation disturbances caused by the level of hemodilution these patients may encounter.","PeriodicalId":383221,"journal":{"name":"International Journal of Clinical Transfusion Medicine","volume":"27 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130004161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Spectra Optia® Apheresis System: current insights into clinical risks and benefits Spectra Optia®单采系统:目前对临床风险和益处的见解
International Journal of Clinical Transfusion Medicine Pub Date : 2018-12-01 DOI: 10.2147/IJCTM.S104333
A. Klink, S. Rummler
{"title":"Spectra Optia® Apheresis System: current insights into clinical risks and benefits","authors":"A. Klink, S. Rummler","doi":"10.2147/IJCTM.S104333","DOIUrl":"https://doi.org/10.2147/IJCTM.S104333","url":null,"abstract":"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). International Journal of Clinical Transfusion Medicine 2018:6 33–40 International Journal of Clinical Transfusion Medicine Dovepress","PeriodicalId":383221,"journal":{"name":"International Journal of Clinical Transfusion Medicine","volume":"34 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127460961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chemotherapy-induced anemia: etiology, pathophysiology, and implications for contemporary practice 化疗引起的贫血:病因、病理生理学和对当代实践的影响
International Journal of Clinical Transfusion Medicine Pub Date : 2018-11-01 DOI: 10.2147/IJCTM.S187569
E. Bryer, D. Henry
{"title":"Chemotherapy-induced anemia: etiology, pathophysiology, and implications for contemporary practice","authors":"E. Bryer, D. Henry","doi":"10.2147/IJCTM.S187569","DOIUrl":"https://doi.org/10.2147/IJCTM.S187569","url":null,"abstract":": Chemotherapy-induced anemia (CIA) is a multifaceted entity influenced by a variety of patient- and treatment-specific factors. Some sources of variation within CIA include chemotherapeutic agent as well as dose and administration schedule, type and stage of malignancy, baseline pretreatment hemoglobin, target hemoglobin, timing of intervention (red blood cell transfusion, iron, erythropoietin stimulating agent), nutritional status, renal function, age, and gender. The diversity of patient presentation and symptomatology within the broader spectrum of CIA contributes to the challenge of establishing universal criteria to govern optimal management therapies. This manuscript will review the development and evolution of CIA with an emphasis on assorted therapeutic interventions.","PeriodicalId":383221,"journal":{"name":"International Journal of Clinical Transfusion Medicine","volume":"34 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114303614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 45
Transfusion and refusal: trials and tribulations 输血与拒绝:考验与磨难
International Journal of Clinical Transfusion Medicine Pub Date : 2018-07-01 DOI: 10.2147/ijctm.s150554
O. Garraud, J. Tissot
{"title":"Transfusion and refusal: trials and tribulations","authors":"O. Garraud, J. Tissot","doi":"10.2147/ijctm.s150554","DOIUrl":"https://doi.org/10.2147/ijctm.s150554","url":null,"abstract":"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). International Journal of Clinical Transfusion Medicine 2018:6 15–20 International Journal of Clinical Transfusion Medicine Dovepress","PeriodicalId":383221,"journal":{"name":"International Journal of Clinical Transfusion Medicine","volume":"2 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122670665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书